Positron emission tomography (PET) is a quantitative molecular imaging modality
increasingly used to study pulmonary disease processes and drug effects on those …

Lung diseases cause significant morbidity and mortality and lead to high healthcare
utilization. However, few lung disease-specific biomarkers are available to accurately …

Millions of people are affected by respiratory diseases, leading to a significant health burden
globally. Because of the current insufficient knowledge of the underlying mechanisms that …

Inflammatory lung disease is one of the most common clinical scenarios, and yet, it is often
poorly understood. Inflammatory lung disorders, such as chronic obstructive pulmonary …

The continued progression of chronic lung disease despite current treatment options has led
to the increasing evaluation of molecular imaging tools for diagnosis, treatment planning …

Positron emission tomography (PET) combined with computed tomography (CT) is an
established diagnostic modality that has become an essential imaging tool in oncological …

Interstitial lung diseases (ILDs) are a heterogeneous group of conditions, with a wide and
complex variety of imaging features. Difficulty in monitoring, treating and exploring novel …

Background Respiratory diseases are one of the leading causes of death worldwide, yet
effective treatment options remain limited. Although inflammation is thought to be a key …

Positron emission tomography (PET) is an important imaging modality for personalizing
clinical management of patients with lung cancer. In this regard, PET imaging is essential for …

18F-FDG positron emission tomographic (PET) scanning is a major imaging tool widely
used to investigate lung function and lung disease. Tomographic imaging of drug delivered …